Traders should monitor the stock for a move toward the $102.50 cash consideration, with potential upside if the market assigns value to the CVRs. Key catalysts to watch are the filing of the proxy statement, the shareholder vote, and regulatory clearance under the HSR Act. The deal is not subject to a financing condition, reducing execution risk.
Price Chart
Executive Summary
Lantheus (LNTH) has entered into a definitive merger agreement with Curium US Holdings LLC, a private equity-backed radiopharmaceutical company. Curium will acquire all outstanding LNTH shares for $102.50 per share in cash at closing, plus up to $12.00 per share in non-transferable Contingent Value Rights (CVRs) tied to commercial milestones, for total consideration up to $114.50 per share. The cash consideration represents a significant premium to the unaffected stock price, and the transaction has been unanimously approved by Lantheus's Board. The merger is expected to close in the first half of 2027, subject to shareholder and regulatory approvals, and is not subject to a financing condition.
Key Financial Metrics
Key Facts
- Curium US Holdings LLC will acquire Lantheus for $102.50 per share in cash plus up to $12.00 per share in CVRs.
- Total potential consideration is up to $114.50 per share, with the cash portion representing a 38% premium to the unaffected 60-day VWAP.
- The transaction has been unanimously approved by Lantheus's Board of Directors.
- The merger is expected to close in the first half of 2027, subject to shareholder and regulatory approvals (including HSR).
- The consummation of the Merger is not subject to any financing condition.
- Lantheus will suspend its previously issued FY2026 guidance and pause its CEO search.
- The Board approved a $6.0 million transaction bonus pool for certain employees, including $4.0 million for CEO Mary Anne Heino and $500,000 for General Counsel Daniel M. Niedzwiecki.
- Amended severance agreements were entered into with named executive officers to clarify treatment of converted equity awards and 2026 bonuses upon a qualifying termination post-closing.
Financial Impact
Total transaction value up to ~$8.0 billion based on ~69.8M fully diluted shares at $114.50/share. Cash consideration of $102.50/share represents a 38% premium to the unaffected 60-day VWAP.
Risk Factors
- Failure to obtain shareholder approval for the merger.
- Regulatory challenges or delays in obtaining antitrust (HSR) and other required approvals.
- Risk that the commercial milestones for the CVRs are not achieved, resulting in no additional payout.
- Potential for a competing superior proposal to emerge, triggering a termination fee.
- Execution risk in integrating Lantheus into Curium's operations.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (LNTH) — Batch item 1 | 0001193125-26-331138 |
| Document: d167446d8k.htm | 0001193125-26-331150 |
| Document: d167446dex102.htm | 0001193125-26-331138 |
| Document: d167446dex101.htm | 0001193125-26-331138 |
| Document: 0001193125-26-331138-index-headers.html | 0001193125-26-331138 |
| Document: 0001193125-26-331138-index.html | 0001193125-26-331138 |
| Document: 0001193125-26-331138.txt | 0001193125-26-331138 |
| DEFA14A Filing (LNTH) — Batch item 8 | 0001193125-26-331150 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 5d ago | 8-K | $100.10 $99.80 | ▼ −0.30% | ▲ +0.22% | $100.13 (+0.03%) |
Oct 2, 2026 24d ago | DEFA14A | $100.19 $99.95 | ▼ −0.24% | ▼ −0.79% | $100.13 (−0.06%) |
Oct 2, 2026 24d ago | 8-K | $100.19 $99.95 | ▼ −0.24% | ▼ −0.79% | $100.13 (−0.06%) |
Sep 16, 2026 5w ago | DEFA14A | $100.80 $100.55 | ▼ −0.25% | ▼ −0.38% | $100.13 (−0.66%) |
Aug 26, 2026 8w ago | PREM14A | $100.82 $100.47 | ▼ −0.35% | ▼ −1.00% | $100.13 (−0.68%) |
Aug 14, 2026 10w ago | Press Release | $100.95 $100.91 | ▼ −0.04% | ▲ +0.43% | $100.13 (−0.81%) |
Aug 6, 2026 11w ago | 8-K | $101.07 $100.95 | ▼ −0.12% | ▼ −0.73% | $100.13 (−0.93%) |
Aug 3, 2026 12w ago | 8-K / DEFA14A | $101.11 $101.50 | ▲ +0.39% | ▲ +0.59% | $100.13 (−0.97%) |
Aug 3, 2026 12w ago | DEFA14A / 8-K | $101.19 $101.11 | ▼ −0.08% | ▼ −1.88% | $100.13 (−1.05%) |
Aug 3, 2026 12w ago | Press Release | $101.19 $101.11 | ▼ −0.08% | ▼ −1.88% | $100.13 (−1.05%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers